MedTrace Logo

Incretin Effect in Patients With Psoriasis and Controls

NCT06064084 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 24

Last updated 2023-10-03

No results posted yet for this study

Summary

To investigate the incretin effect and postprandial incretin responses in plasma in patients with psoriasis

Conditions

  • Psoriasis Vulgaris

Interventions

DIAGNOSTIC_TEST

Oral glucose tolerance test

Oral glucose tolerance test 50g

OTHER

Intravenous isoglycaemic glucose clamp

Intravenous isoglycaemic glucose clamp

OTHER

Liquid Mixed meal test

Liquid Mixed meal test 520 kcal

Sponsors & Collaborators

  • University Hospital, Gentofte, Copenhagen

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-09-11
Primary Completion
2015-09-11
Completion
2015-09-11

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06064084 on ClinicalTrials.gov